Glen Eagle Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.9K | Sell |
|
|||||
|
2025
Q2 | $74.8K | Sell |
|
|||||
|
2025
Q1 | $152K | Sell |
|
|||||
|
2024
Q4 | $643K | Sell |
|
|||||
|
2024
Q3 | $882K | Sell |
|
|||||
|
2024
Q2 | $1.33M | Buy |
|
|||||
|
2024
Q1 | $904K | Buy |
|
|||||
|
2023
Q4 | $157K | Buy |
|
|||||
|
2023
Q3 | $46.2K | Hold |
|
|||||
|
2023
Q2 | $62.9K | Hold |
|
|||||
|
2023
Q1 | $55.2K | Hold |
|
|||||
|
2022
Q4 | $49.8K | Hold |
|
|||||
|
2022
Q3 | $55.1K | Hold |
|
|||||
|
2022
Q2 | $63.4K | Hold |
|
|||||
|
2022
Q1 | $78.5K | Hold |
|
|||||
|
2021
Q4 | $86.4K | Hold |
|
|||||
|
2021
Q3 | $75.5K | Sell |
|
|||||
|
2021
Q2 | $71.5K | Hold |
|
|||||
|
2021
Q1 | $57.7K | Hold |
|
|||||
|
2020
Q4 | $62.9K | Sell |
|
|||||
|
2020
Q3 | $61.1K | Sell |
|
|||||
|
2020
Q2 | $53.1K | Buy |
|
|||||
|
2020
Q1 | $43.4K | Sell |
|
|||||
|
2019
Q4 | $61.4K | Buy |
|
|||||
|
2019
Q3 | $57.6K | Buy |
|
|||||
|
2019
Q2 | $42.5K | Hold |
|
|||||
|
2019
Q1 | $44K | Hold |
|
|||||
|
2018
Q4 | $35.2K | Sell |
|
|||||
|
2018
Q3 | $44.4K | Sell |
|
|||||
|
2018
Q2 | $37.7K | Sell |
|
|||||
|
2018
Q1 | $36.3K | Buy |
|
|||||
|
2017
Q4 | $2.14K | Sell |
|
|||||
|
2017
Q3 | $50K | Buy |
|
|||||
|
2017
Q2 | $23.6K | Buy |
|
|||||
|
2017
Q1 | $16.5K | Buy |
|
|||||
|
2016
Q4 | $11.7K | Buy |
|